Although circUCK2(2,3) can activate EGFR, neither overexpression nor knockdown of circUCK2(2,3) affected the response to lenvatinib in HCC cells (Fig. S12E and F), suggesting that the underlying mechanism of EGFR-induced lenvatinib resistance is complicated. Here, EGFR is linked to hepatocellular carcinoma.